Tex.
Health & Safety Code Section 51.0003
Requirements; Notice
(a)
The program:(1)
must collaborate with physicians and health care providers to notify a prospective subject about the program when:(A)
the prospective subject provides informed consent for a cancer clinical trial; or(B)
funding is available to provide the program for the cancer clinical trial in which the prospective subject participates;(2)
must reimburse subjects based on financial need, which may include reimbursement to subjects whose income is at or below 700 percent of the federal poverty level;(3)
must provide reimbursement for ancillary costs, including costs described by Section 51.0002 (Establishment), to eliminate the financial barriers to enrollment in a clinical trial;(4)
may provide reimbursement for reasonable ancillary costs, including costs described by Section 51.0002 (Establishment), to one family member, friend, or other person who attends a cancer clinical trial to support a subject; and(5)
must comply with applicable federal and state laws.(b)
The independent, third-party organization administering the program shall provide written notice to prospective subjects of the requirements described by Subsection (a).
Source:
Section 51.0003 — Requirements; Notice, https://statutes.capitol.texas.gov/Docs/HS/htm/HS.51.htm#51.0003 (accessed May 4, 2024).
